Rice Hall James & Associates’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
GJL
Rice Hall James & Associates's CLB Position: Q3 2026 in Review
Rice Hall James & Associates reduced its Core Laboratories (CLB) stake by 14% in Q3 2026, selling an estimated $163K and leaving 87,610 shares worth $850K. The position accounts for 0.05% of the portfolio, ranked #190.
Rice Hall James & Associates first reported a position in CLB in Q1 2015 and has held it in 25 quarters since. The position peaked at $3.74M in Q2 2015. 180 funds tracked by Wall St. Rank hold CLB as of Q3 2026.
- Rice Hall James & Associates held 87,610 shares of Core Laboratories worth $850K as of Q3 2026.
- Rice Hall James & Associates sold 14,038 Core Laboratories shares in Q3 2026, an estimated $163K.
- Core Laboratories made up 0.05% of Rice Hall James & Associates's portfolio in Q3 2026, its #190 holding.
- Rice Hall James & Associates first reported a position in Core Laboratories in Q1 2015 and has held it in 25 quarters since.
- Rice Hall James & Associates's Core Laboratories position peaked at $3.74M in Q2 2015.
- 180 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2026.
Based on Rice Hall James & Associates's 13F filing for Q3 2026, filed 16 Nov 2026.